Institution
Public Health Research Institute
Healthcare•
About: Public Health Research Institute is a based out in . It is known for research contribution in the topics: Population & Randomized controlled trial. The organization has 4889 authors who have published 8149 publications receiving 276945 citations.
Papers published on a yearly basis
Papers
More filters
••
172 citations
••
TL;DR: Low-quality evidence is found that music-based therapeutic interventions for people with dementia may have little or no effect on emotional well-being and quality of life, and future studies should employ larger sample sizes.
Abstract: BACKGROUND: Dementia is a clinical syndrome with a number of different causes which is characterised by deterioration in cognitive, behavioural, social and emotional functions. Pharmacological interventions are available but have limited effect to treat many of the syndrome's features. Less research has been directed towards non-pharmacological treatments. In this review, we examined the evidence for effects of music-based interventions. OBJECTIVES: To assess the effects of music-based therapeutic interventions for people with dementia on emotional well-being including quality of life, mood disturbance or negative affect, behavioural problems, social behaviour and cognition at the end of therapy and four or more weeks after the end of treatment. SEARCH METHODS: We searched ALOIS, the Specialized Register of the Cochrane Dementia and Cognitive Improvement Group (CDCIG) on 19 June 2017 using the terms: music therapy, music, singing, sing, auditory stimulation. Additional searches were carried out on 19 June 2017 in the major healthcare databases MEDLINE, Embase, PsycINFO, CINAHL and LILACS; and in trial registers and grey literature sources. SELECTION CRITERIA: We included randomised controlled trials of music-based therapeutic interventions (at least five sessions) for people with dementia that measured any of our outcomes of interest. Control groups either received usual care or other activities with or without music. DATA COLLECTION AND ANALYSIS: Two review authors worked independently to screen the retrieved studies against the inclusion criteria and then to extract data and assess methodological quality of the included studies. If necessary, we contacted trial authors to ask for additional data, including relevant subscales, or for other missing information. We pooled data using random-effects models. MAIN RESULTS: We included 22 studies with 1097 randomised participants. Twenty-one studies with 890 participants contributed data to meta-analyses. Participants in the studies had dementia of varying degrees of severity, and all were resident in institutions. Seven studies delivered an individual music intervention; the other studies delivered the intervention to groups of participants. Most interventions involved both active and receptive musical elements. The methodological quality of the studies varied. All were at high risk of performance bias and some were at high risk of detection or other bias.At the end of treatment, we found low-quality evidence that the interventions may improve emotional well-being and quality of life (standardised mean difference (SMD) 0.32, 95% confidence interval (CI) 0.02 to 0.62; 9 studies, 348 participants) and reduce anxiety (SMD -0.43, 95% CI -0.72 to -0.14; 13 studies, 478 participants). We found low-quality evidence that music-based therapeutic interventions may have little or no effect on cognition (SMD 0.15, 95% CI -0.06 to 0.36; 7 studies, 350 participants). There was moderate-quality evidence that the interventions reduce depressive symptoms (SMD -0.27, 95% CI -0.45 to -0.09; 11 studies, 503 participants) and overall behaviour problems (SMD -0.23, 95% CI -0.46 to -0.01; 10 studies, 442 participants), but do not decrease agitation or aggression (SMD -0.07, 95% CI -0.24 to 0.10; 14 studies, 626 participants). The quality of the evidence on social behaviour was very low, so effects were very uncertain.The evidence for long-term outcomes measured four or more weeks after the end of treatment was of very low quality for anxiety and social behaviour, and for the other outcomes, it was of low quality for little or no effect (with small SMDs, between 0.03 and 0.34). AUTHORS' CONCLUSIONS: Providing people with dementia who are in institutional care with at least five sessions of a music-based therapeutic intervention probably reduces depressive symptoms and improves overall behavioural problems at the end of treatment. It may also improve emotional well-being and quality of life and reduce anxiety, but may have little or no effect on agitation or aggression or on cognition. We are uncertain about effects on social behaviour and about long-term effects. Future studies should examine the duration of effects in relation to the overall duration of treatment and the number of sessions.
171 citations
••
TL;DR: To assess the stability and reliability of I2 estimates and their 95% CIs, in relation to the cumulative number of trials and events in meta-analysis, this work looked at 16 large Cochrane meta-analyses - each including a sufficient number of Trials and events to reliably estimate I2 - and monitored the I2 Estimates and their 93% confidence intervals for each year of publication.
Abstract: Background Assessment of heterogeneity is essential in systematic reviews and meta-analyses of clinical trials. The most commonly used heterogeneity measure, I2, provides an estimate of the proportion of variability in a meta-analysis that is explained by differences between the included trials rather than by sampling error. Recent studies have raised concerns about the reliability of I2 estimates, due to their dependence on the precision of included trials and time-dependent biases. Authors have also advocated use of 95% confidence intervals (CIs) to express the uncertainty associated with I2 estimates. However, no previous studies have explored how many trials and events are required to ensure stable and reliable I2 estimates, or how 95% CIs perform as evidence accumulates. Methodology/Principal Findings To assess the stability and reliability of I2 estimates and their 95% CIs, in relation to the cumulative number of trials and events in meta-analysis, we looked at 16 large Cochrane meta-analyses - each including a sufficient number of trials and events to reliably estimate I2 - and monitored the I2 estimates and their 95% CIs for each year of publication. In 10 of the 16 meta-analyses, the I2 estimates fluctuated more than 40% over time. The median number of events and trials required before the cumulative I2 estimates stayed within +/−20% of the final I2 estimate was 467 and 11. No major fluctuations were observed after 500 events and 14 trials. The 95% confidence intervals provided good coverage over time. Conclusions/Significance I2 estimates need to be interpreted with caution when the meta-analysis only includes a limited number of events or trials. Confidence intervals for I2 estimates provide good coverage as evidence accumulates, and are thus valuable for reflecting the uncertainty associated with estimating I2.
171 citations
••
TL;DR: Time from acquisition of infection to development of clinical disease does not reliably predict the radiographic appearance of tuberculosis, and human immunodeficiency virus status, a probable surrogate for the integrity of the host immune response, is the only independent predictor of radiography appearance.
Abstract: ContextThe traditional teaching that pulmonary tuberculosis characterized by
lymphadenopathy, effusions, and lower or mid lung zone infiltrates on chest
radiography represents “primary” disease from recently acquired
infection, whereas upper lobe infiltrates and cavities represent secondary
or reactivation disease acquired in the more distant past, is not based on
well-established clinical evidence. Furthermore, it is not known whether the
atypical radiograph common in human immunodeficiency virus (HIV)–associated
tuberculosis is due to a preponderance of primary progressive disease or altered
immunity.ObjectiveTo analyze the relationship between recently acquired and remotely acquired
pulmonary tuberculosis, clinical and demographic variables, and radiographic
features by using molecular fingerprinting and conventional epidemiology.Design, Setting, and PopulationA retrospective, hospital-based series of 456 patients treated at a
New York City medical center between 1990 and 1999. Eligible patients had
to have had at least 1 positive respiratory culture for Mycobacterium tuberculosis and available radiographic data.Main Outcome MeasuresRadiographic appearance as measured by the presence or absence of 6
features: upper lobe infiltrate, cavitary lesion, adenopathy, effusions, lower
or mid lung zone infiltrate, and miliary pattern. Radiographs were considered typical if they had an upper lobe infiltrate or cavity whether or not
other features were present. Atypical radiographs
were those that had adenopathy, effusion, or mid lower lung zone infiltrates
or had none of the above features.ResultsHuman immunodeficiency virus infection was most commonly associated
with an atypical radiographic appearance on chest radiograph with an odds
ratio of 0.20 (95% confidence interval, 0.13-0.31). Although a clustered fingerprint,
representing recently acquired disease, was associated with typical radiograph
in univariate analysis (odds ratio, 0.68; 95% confidence interval, 0.47-0.99),
the association was lost when adjusted for HIV status.ConclusionsTime from acquisition of infection to development of clinical disease
does not reliably predict the radiographic appearance of tuberculosis. Human
immunodeficiency virus status, a probable surrogate for the integrity of the
host immune response, is the only independent predictor of radiographic appearance.
The altered radiographic appearance of pulmonary tuberculosis in HIV is due
to altered immunity rather than recent acquisition of infection and progression
to active disease.
170 citations
••
TL;DR: The interpretation of the present findings is that plasmid establishment is not a unitary event subsuming both ability to replicate and hereditary stabilization; correspondingly, the incompatibility barrier appears to have at least two separate components, namely a temporary inhibition of replication and a much longer inhibition of hereditary stabilization.
170 citations
Authors
Showing all 4916 results
Name | H-index | Papers | Citations |
---|---|---|---|
Dorret I. Boomsma | 176 | 1507 | 136353 |
Brenda W.J.H. Penninx | 170 | 1139 | 119082 |
Michael Snyder | 169 | 840 | 130225 |
Lex M. Bouter | 158 | 767 | 103034 |
David Eisenberg | 156 | 697 | 112460 |
Philip Scheltens | 140 | 1175 | 107312 |
Pim Cuijpers | 136 | 982 | 69370 |
Gonneke Willemsen | 129 | 575 | 76976 |
Britton Chance | 128 | 1112 | 76591 |
Coen D.A. Stehouwer | 122 | 970 | 59701 |
Peter J. Anderson | 120 | 966 | 63635 |
Jouke-Jan Hottenga | 120 | 389 | 63039 |
Eco J. C. de Geus | 119 | 522 | 61085 |
Johannes Brug | 109 | 620 | 44832 |
Paul Lips | 109 | 491 | 50403 |